epigallocatechin gallate has been researched along with Colitis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Liu, S; Ma, L; Ma, Y; Ramos-Mucci, L; Sun, J; Xiao, B; Yang, X; Zhang, J; Zhu, Z | 1 |
| Li, X; Lv, H; Shi, F; Wang, W; Zhang, Z | 1 |
| Li, M; Weigmann, B | 1 |
| Baig, S; Ding, H; Du, Y; Hicks, J; Mohan, C; Soomro, S; Vanarsa, K | 1 |
| Hasegawa, N; Mochizuki, M | 1 |
| Brückner, M; Domschke, W; Kucharzik, T; Lügering, A; Westphal, S | 1 |
| Chiou, YS; Ho, CT; Ma, NJ; Pan, MH; Sang, S; Wang, YJ | 1 |
| Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z | 1 |
| Abboud, PA; Burroughs, TJ; Hake, PW; Mangeshkar, P; O'Connor, M; Odoms, K; Wong, HR; Zingarelli, B | 1 |
| Chen, C; Ran, ZH; Xiao, SD | 1 |
10 other study(ies) available for epigallocatechin gallate and Colitis
| Article | Year |
|---|---|
Oral antimicrobial peptide-EGCG nanomedicines for synergistic treatment of ulcerative colitis.
Topics: Animals; Antimicrobial Peptides; Catechin; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Inflammation; Lipopolysaccharides; Mice; Nanomedicine; RAW 264.7 Cells | 2022 |
Study on the preparation of EGCG-γ-Cyclodextrin inclusion complex and its drug-excipient combined therapeutic effects on the treatment of DSS-induced acute ulcerative colitis in mice.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Excipients; gamma-Cyclodextrins; Interleukin-6; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha | 2023 |
Effect of a Flavonoid Combination of Apigenin and Epigallocatechin-3-Gallate on Alleviating Intestinal Inflammation in Experimental Colitis Models.
Topics: Animals; Apigenin; Caco-2 Cells; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Flavonoids; Humans; Inflammation; Inflammatory Bowel Diseases | 2023 |
Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability.
Topics: Animals; Anti-Inflammatory Agents; Catechin; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Agents; Inflammation Mediators; Macrophages; Male; Mice, Inbred C57BL; Permeability; T-Lymphocytes | 2019 |
(-)-Epigallocatechin-3-gallate reduces experimental colon injury in rats by regulating macrophage and mast cell.
Topics: Animals; Catechin; Chemotaxis; Colitis; Histamine; Macrophages; Male; Mast Cells; N-Formylmethionine Leucyl-Phenylalanine; Peroxidase; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 2010 |
Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis.
Topics: Alkaloids; Analysis of Variance; Animals; Antioxidants; Benzodioxoles; Catechin; Colitis; Dextran Sulfate; Female; Glutathione Peroxidase; HT29 Cells; Humans; Interleukin-8; Malondialdehyde; Mice; Mice, Inbred C57BL; Oxidative Stress; Peroxidase; Piperidines; Polyunsaturated Alkamides; Reactive Oxygen Species; Superoxide Dismutase; Weight Loss | 2012 |
Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice.
Topics: Acetates; Acetylation; Animals; Catechin; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Dextran Sulfate; Down-Regulation; Gene Expression; Humans; Male; Mice; Mice, Inbred ICR; Premedication; Signal Transduction | 2012 |
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss | 2012 |
Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis.
Topics: Animals; Antioxidants; Catechin; Colitis; Cytokines; Disease Models, Animal; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; Peroxidase; Tea; Transcription Factor AP-1; Trinitrobenzenesulfonic Acid | 2008 |
Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid.
Topics: Acetic Acid; Animals; Catechin; Colitis; Cytokines; Indicators and Reagents; Interferon-gamma; Intestinal Mucosa; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2008 |